Search Results 181-190 of 16798 for Joseph Murray

  1. Health Topics - Mayo Clinic News Network

    Joe Dangor. April 4, 2022. First · Previous ... 187 · 188 · 189 · 190 · 191 · 192 · 193 ... Next · Last. Explore more topics. Scroll backwards. Biotherapeutics ...

  2. A Study to Evaluate the Effectiveness and Safety of Larazotide Acetate for the Relief of CeD Symptoms - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Joseph Murray, M.D.. Contact information: Carol Van Dyke CCRP. (507) ...

  3. Functional Gastrointestinal Disease, Celiac Disease, and Non-celiac Gluten Sensitivity in an Olmsted County Cohort - Mayo Clinic

    Joseph Murray, M.D.. Contact information: Chadrick Hinson. (507) 538-6300. Contact UsHinson.Chadrick@mayo.edu. Closed-enrolling by invitation. What is this ...

  4. A Study to Assess the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Celiac Disease Patients - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  5. A Study of the Response to and Changes in Intestinal Permeability 4 hours after a Gluten Challenge in Subjects with Celiac Disease and Non Celiac Gluten Sensitivity - Mayo Clinic

    Joseph Murray, M.D.. Contact information: Carol Van Dyke CCRP. (507)266-7842. Contact UsVanDyke.Carol@mayo.edu. Closed for enrollment. More information ...

  6. Faculty - Department of Cancer Biology - Mayo Clinic Research

    Murray, Nicole R. Ph.D. murray.nicole@mayo.edu; Associate Professor of Cancer Biology; Assistant Professor of Pharmacology. More about research at Mayo ...

  7. Mayo Clinic Study of Thousands of Brains Reveals Tau as Driver of Alzheimer’s Disease

    Murray says. “Initially, patients who were discovered to have mutations or changes in the amyloid gene were found to have severe Alzheimer's pathology — ...

  8. A Study of the Safety, Effectiveness and Tolerability of Nexvax-2 in Patients with Celiac Disease (CeD) - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  9. Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic Celiac Disease Patients - Mayo Clinic

    Joseph Murray, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  10. A Study to Evaluate the Safety, Tolerability, and Clinical Benefit of AK002 in Adult Patients with Mast Cell Gastritis and/or Gastroenteritis

    Joseph Murray, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...